Biodel has announced plans to submit a New Drug Application (NDA) to the FDA in 2015 for a novel glucagon rescue device to treat severe hypoglycemia.
Having previously signed a long-term commercial supply agreement for bulk glucagon, Biodel expects to select a final formulation of its novel glucagon therapy...
We are balancing the need to maintain good blood glucose control with the fear of hypoglycemia. This fear is well founded. Hypoglycemia is not just unpleasant and embarrassing- it can be fatal.